Additionally, we used metabolomeic methods to analyze the metabolites in mouse blood samples and searched for potential biomarkers of AKI at the level of endogenous metabolites, attempting to elucidate the mechanisms of CDDP-induced AKI and Fas-mediated renal protection. The gene discussed is FAS; the disease is acute kidney injury.